PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
April 25, 2013 | ISSUE NUMBER 297 VOL 10

Healthcare Reform
Congress 'Tip Toes Around Obamacare'
Of the many issues involved with the implementation of the 2010 Affordable Care Act, few are more intriguing than those that personally impact Members of Congress (MOCs).  Today, MOCs are facing a clear legal mandate that requires them to sign up for Obamacare. But according to a recent article, these same Members and their staffs are looking for ways to deftly tip toe around this mandate, set to begin January 1, 2014 ...Read more

Cegedim Relationship Management
2013 Trends in Aggregate Spend and Disclosure Compliance - Complimentary Report
Cegedim Relationship Management's annual report discovers 89% will utilize an automated reporting solution for Sunshine Act compliance;   nearly 60% plan to use a third-party solution.  The report provides a comprehensive overview of how increased transparency is affecting US pharmaceutical and medical device industries.  To read more, download the complimentary report today.

Marketing
Forget Digital Differentiation: Focus on ‘Cross-Channel Fusion’
Companies are coming to realize that digital is not just about “differentiation” and “innovation” — the next stage is “fusion”, the integration of digital into the overall marketing mix ...Read More

CEO Compensation Data
Complete salary, bonus & market capitalization data in biotech.
www.bioworld.com

Marketing
Digital Innovation: A Call to Action
The life science industry has a history of driving innovation through scientific progress in new treatments, devices, and services that improve health and wellness. Yet for an industry so steeped in cutting-edge science and technology, why is its approach to marketing still so staid, inflexible, and irrelevant, asks David Ormesher
...Read more

Verifying Your Aggregate Spend Program and Transparency Reports
Live Webcast: Tuesday, April 30, 2013 at 11:00 am ET
Register Free at: www.pharmexec.com/aggspend

Global
Tough Times Ahead for New Medicines under NHS England?
This month, NHS England (formerly the NHS Commissioning Board) set out 15 commissioning policies in 250 pages. They’re important, writes Leela Barham, as they set out the approach NHS England will take when they’re spending some £20 billion plus worth of services
...Read more

Marketing to Professionals
Pharm Exec’s What Physician’s Want Vol. I & II
How, when and why physicians consume information. Information on marketing, detailing, sampling, prescribing, CME, conventions and meetings from some of the best in the industry.  Best methods to communicate with docs.  New ideas from reorganization to alternative sales channels to embedded outsourcing
...Read more

// Stephen Williams, formerly a Vice President at Pfizer, joined the Board of Venaxis (Castle Rock, CO).//Precision for Medicine (Chevy Chase, MD) appointed former US FDA senior adviser Dr Vicki Seyfert-Margolis as Chief of Science and Strategy.//Celgene (Summit, NJ) CEO and Chairman Robert Hugin was appointed Chairman Elect of the Pharmaceutical Research and Manufacturers of America (PhRMA). He succeeds Lilly's John Lechleiter.//Prismic Pharmaceuticals, Inc. (Scottsdale, AZ) announced the appointment of a number of International Advisors to its International Commercial Advisory Board. They are Antoni Esteve, PhD (Spain); Cosimo Pulli, PhD (Italy); Massimo Bonsi (Eastern Europe) and Anthony H. Wild, Ph.D. Prismic also appointed Marco Cartolari as a Special Advisor to the Board of Directors.//

April 29–30: 12th Annual Patient Adherence and Support Summit
Philadelphia, PA.


May 6–7: CBI’s 10th Forum on Patient Reported Outcomes
Philadelphia, PA.


May 21–22: Regulatory Submission and Reporting Strategies
Washington, DC.


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin


Survey
Has your department been downsized? If yes, by how much?

Click To Vote
Quick Links

UK Measles Outbreak: The Need for Balance in Healthcare Communications

Safety Trumps Access to Pain Meds for FDA

Ad Agency Encourages Pharma Marketers to Reboot